Semaglutide Side Effects: Common Ones and How to Manage Them

‍What are the most common semaglutide side effects?

Semaglutide belongs to a class of medications called GLP-1 receptor agonists. It works by mimicking a naturally occurring hormone in your body that regulates appetite control and blood sugar. Because it also affects your digestive system – specifically by slowing down how fast your stomach empties (gastric emptying) – the vast majority of side effects are gastrointestinal.

Semaglutide is available in several dosage forms, including injectable pens and oral tablets. Common brand names for semaglutide include Ozempic, Wegovy, and Rybelsus. These medicines are primarily used to improve blood sugar control in people with type 2 diabetes and to support weight management in individuals with obesity or overweight.

According to clinical trials and real-world data, the most common side effects include:

• Nausea: This is by far the most frequently reported side effect. It usually occurs when you first start the medication or when you increase your dose.

• Diarrhea and Constipation: Changes in bowel movements and problems digesting food are very common. Slower digestion allows the body to absorb more water from the intestines, which can lead to hard stools and constipation. Conversely, some patients experience diarrhea as their digestive system adapts.

• Vomiting: Usually linked to severe nausea or eating portions that are too large for the newly slowed digestive tract.

• Heartburn and Acid Reflux: Because food stays in the stomach longer, the risk of stomach acid pressing up into the esophagus increases.

• Gas and Bloating: Slower digestion can lead to a buildup of gas, causing an uncomfortable, bloated feeling. Excess air in the stomach or bowels can also contribute to bloating and discomfort.

• Fatigue: Feeling unusually tired is common, particularly during the initial phase of treatment. This is often related to reduced caloric intake rather than a direct pharmacological effect of semaglutide.

For the vast majority of patients, these side effects are transient. They are typically mild to moderate and gradually subside as your body builds a tolerance to the medication.

Other side effects of semaglutide

While semaglutide is generally safe and well tolerated when prescribed and monitored by a healthcare professional, it is a potent pharmacological treatment. In addition to common gastrointestinal effects, there are less frequent but potentially more serious adverse events to be aware of.

• Gallbladder issues (Gallstones): Rapid and substantial weight loss—regardless of the method used—increases the risk of developing gallstones.

• Pancreatitis: Acute pancreatitis has been reported in patients treated with GLP-1 receptor agonists. Although rare, it is considered a serious adverse event. Patients should seek immediate medical attention if they develop persistent, severe abdominal pain, which may radiate to the back. A history of pancreatitis warrants careful medical evaluation before treatment initiation.

• Hypoglycemia (Low blood sugar): Semaglutide alone carries a low risk of clinically significant hypoglycaemia because its insulin-stimulating effect is glucose dependent. However, when combined with insulin or sulfonylureas, the risk increases. Dose adjustments of concomitant glucose-lowering medications may be required.

• Increased Heart Rate: Some patients experience a slight increase in their resting heart rate while taking semaglutide.

• Allergic reactions: Serious allergic reactions are rare but possible. Patients should seek doctor immediately if they experience symptoms such as difficulty breathing, swelling of the face or throat, or severe rash.

If you notice severe symptoms such as difficulty breathing, severe abdominal pain, or symptoms of low blood sugar (including blurred vision), seek immediate medical attention.

If you want to understand more about how the active ingredient works, [read our comprehensive guide to semaglutide here] (Insert internal link to Semaglutid page).

Potential Interactions and Side effects

Semaglutide has a relatively low potential for clinically significant drug–drug interactions. However, certain considerations are important.

Semaglutide may increase the risk of low blood sugar when used in combination with insulin or sulfonylureas. In such cases, dose adjustments of concomitant glucose-lowering therapies may be required.

Because semaglutide slows gastric emptying, it may delay the absorption of orally administered medications. Caution may be warranted in patients taking medications with a narrow therapeutic index.

Patients should inform their healthcare provider about all medications they are taking, including dietary supplements, prescription drugs, over-the-counter products, herbal or vitamin supplements.

Before initiating treatment, clinicians should review the patient’s medical history, previous weight loss attempts, and factors contributing to weight regain. Ongoing clinical monitoring is recommended, particularly in patients with type 2 diabetes with diabetes medicine dosing changes or complex comorbidities.

Finally, remember that lifestyle changes—such as a balanced diet and regular exercise—are key to managing blood sugar levels and achieving sustainable weight loss. Work closely with your health care team or a digital model for modern obesity care to develop a comprehensive plan that includes semaglutide, if appropriate, and ongoing monitoring for any potential side effects.

How do you avoid side effects of semaglutide?

Gastrointestinal side effects such as nausea, fullness, or mild digestive discomfort are most common during the early stages of treatment or after dose escalation. However, these symptoms can often be minimized with a structured and individualized approach.

A gradual dose-escalation strategy is key. Following the principle of the lowest effective dose, treatment should be tailored to the individual rather than increased automatically according to a fixed schedule. If a patient achieves meaningful clinical benefit with good tolerability at a lower dose, maintaining that dose may help reduce the likelihood of adverse effects while preserving efficacy.

Dietary Strategies to Minimise Side Effects During Semaglutide Treatment

Dietary habits also play an important role. Patients may reduce the risk of side effects by:

1. Eat smaller, more frequent meals

As gastric emptying is delayed, portions that previously felt appropriate may now be excessive. Large meals can increase the likelihood of nausea, fullness, or vomiting. Using smaller portions and eating modest amounts at a time may improve tolerance.

2. Eat slowly and chew thoroughly

Satiety signals take time to develop. Eating quickly may result in discomfort before fullness is recognized. Slowing down, chewing thoroughly, and pausing between bites can help align intake with the body’s satiety response. Meals lasting at least 15–20 minutes are often better tolerated.

3. Avoid fatty, fried, and overly spicy foods

High-fat and calorie-rich meals delay digestion and may exacerbate nausea, bloating, reflux, or abdominal discomfort when combined with GLP-1 therapy. Choosing lighter meals with balanced macronutrient composition may improve tolerability.

4. Maintain adequate hydration

Reduced appetite may also lead to reduced fluid intake. Dehydration can contribute to constipation, fatigue, and headaches. Regular fluid intake throughout the day is recommended, particularly if experiencing nausea or reduced food intake.

5. Limit alcohol consumption

Alcohol may irritate the gastrointestinal tract and can affect blood glucose regulation, particularly in individuals with type 2 diabetes or those using other glucose-lowering medications. Alcohol may also worsen nausea or reflux symptoms. Patients should discuss alcohol intake with their healthcare provider.

6. Be aware of hypoglycaemia risk (particularly in patients using insulin or sulfonylureas)

Semaglutide alone has a low risk of causing low blood sugar. However, the risk increases when combined with insulin or sulfonylureas. Patients at increased risk should carry fast-acting carbohydrates, such as glucose tablets, to treat symptoms of low blood sugar.

Common symptoms of hypoglycaemia include shakiness, sweating, confusion, dizziness, and palpitations.

When should you seek medical attention for semaglutide side effects?

Mild gastrointestinal symptoms such as nausea, gas, bloating or stomach discomfort, or temporary constipation are common during the initial treatment phase or after dose escalation. These effects often improve as the body adapts. However, certain symptoms warrant prompt medical evaluation.

Contact your healthcare professional or doctor immediately if you experience:

• Severe or persistent abdominal pain

Intense abdominal pain that does not resolve—particularly if it radiates to the back—may indicate pancreatitis or gallbladder disease and requires urgent assessment.

• Inability to maintain hydration

Ongoing vomiting or severe diarrhoea that prevents adequate fluid intake may lead to dehydration. Medical evaluation is recommended if symptoms persist.

• If low blood sugar occurs (diabetic patients at risk)

Semaglutide alone carries a low risk of low blood sugar. However, the risk increases when combined with insulin or sulfonylureas. Symptoms such as confusion, dizziness, sweating, or palpitations may indicate low blood sugar. If this occurs, consume fast-acting carbohydrates (e.g., eat glucose tablets, drink fruit juice or non diet soft drink) and seek doctor immediately if symptoms do not resolve promptly.

• Signs of unusual or allergic reaction

Swelling of the face or throat, trouble breathing, or widespread rash require immediate medical attention.

• Persistent or intolerable side effects

If adverse effects significantly interfere with daily functioning, sleep, or nutritional intake, your health care professional may adjust the dose, modify the titration schedule, or provide supportive treatment.

Support from health care professional

Ongoing medical supervision supports both safety and long-term treatment success. By working closely with your health care team and health care professional, you ensure that your treatment is not only effective but also comfortable and safe for your long-term health through ongoing monitoring and comprehensive weight loss treatment.

References

• Diabetes, Obesity and Metabolism. Semaglutide for the treatment of overweight and obesity: A review.
  ‍https://doi.org/10.1111/dom.14863
• European Medicines Agency (EMA): Wegovy – EPAR (översikt och godkännande)
  https://www.ema.europa.eu/en/medicines/human/EPAR/wegovy
• Journal of Clinical Medicine. Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus.
  https://pmc.ncbi.nlm.nih.gov/articles/PMC9821052/

‍